People who ate more fruits and vegetables as young adults were less likely to develop coronary atherosclerosis 20 years later, according to a recent study co-authored by Northwestern Medicine investigator Philip Greenland, MD.
Browsing: Clinical Breakthroughs
SchizConnect, the first neuroimaging meta-database dedicated to clinical schizophrenia research, will allow scientists to see broader results across many more subjects than ever before.
Francis Giles, MD, chief of Hematology/Oncology in the Department of Medicine, led a clinical study to test the efficacy and safety of a kinase inhibitor for the treatment of chronic myeloid leukemia.
Nina Gotteiner, MD, associate professor of Pediatrics in the Division of Cardiology, studied the outcomes and predictors of fetuses diagnosed with Epstein anomaly or tricuspid valve dysplasia.
Many patients on antihypertensive medications are at greater risk of cardiovascular disease, despite controlled numbers, according to a new Northwestern Medicine study.
An RNA editing technique called ‘exon skipping’ has shown preliminary success in treating a rare and severe form of muscular dystrophy that currently has no treatment.
In a phase three clinical trial, a new enzyme replacement therapy resulted in a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency.
A recent study shows that patients treated for colon cancer who regularly drank caffeinated coffee had lower rates of cancer recurrence and mortality.
Emergency department patients have a range of beliefs and attitudes about the risk of becoming addicted to prescribed opioids, according to a recent study authored by a Feinberg medical student.
A new study co-authored by a Northwestern Medicine scientist found no significant difference between two popular therapy regimens in patients with a subset of Hodgkin lymphoma.